CryoCell Historical Balance Sheet

CCEL Stock

USD 8.73 0.40 4.80%

Trend analysis of CryoCell International balance sheet accounts such as Other Current Liab of 7.7 M, Total Current Liabilities of 25.2 M or Property Plant And Equipment Net of 26.6 M provides information on CryoCell International's total assets, liabilities, and equity, which is the actual value of CryoCell International to its prevalent stockholders. By breaking down trends over time using CryoCell International balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining CryoCell International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CryoCell International is a good buy for the upcoming year.

CryoCell International Inventory

657,390

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

About CryoCell Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CryoCell International at a specified time, usually calculated after every quarter, six months, or one year. CryoCell International Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CryoCell International and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CryoCell currently owns. An asset can also be divided into two categories, current and non-current.

CryoCell International Balance Sheet Chart

At this time, CryoCell International's Non Current Assets Total are quite stable compared to the past year. Non Currrent Assets Other is expected to rise to about 7.3 M this year, although the value of Net Debt will most likely fall to about 9 M.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net Property Plant And Equipment Gross

Add Fundamental

Total Assets

Total assets refers to the total amount of CryoCell International assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CryoCell International books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on CryoCell International balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CryoCell International are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from CryoCell International's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CryoCell International current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.At this time, CryoCell International's Non Current Assets Total are quite stable compared to the past year. Non Currrent Assets Other is expected to rise to about 7.3 M this year, although the value of Net Debt will most likely fall to about 9 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	5.6M	6.4M	7.3M	7.7M
Total Assets	64.9M	61.2M	70.4M	73.9M

Other Current Liab Total Assets

CryoCell International balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Other Current Assets	Short Term Debt	Short Term Investments	Common Stock	Other Liab	Other Assets
Total Assets		0.89	0.94	0.1	0.79	0.57	-0.03	0.74	-0.09	0.97	0.74	-0.05	0.88	-0.49	0.97	0.02	0.97	0.32	0.5	0.66	-0.21	0.61	-0.27	0.87	0.99	0.96
Other Current Liab	0.89		0.9	0.08	0.8	0.46	-0.14	0.79	-0.22	0.91	0.55	-0.21	0.73	-0.29	0.85	0.22	0.87	0.1	0.56	0.42	0.03	0.3	-0.15	0.8	0.88	0.76
Total Current Liabilities	0.94	0.9		-0.15	0.75	0.55	-0.29	0.83	-0.04	0.9	0.63	0.0	0.94	-0.33	0.95	0.18	0.97	0.35	0.41	0.66	-0.1	0.55	-0.12	0.89	0.96	0.89
Total Stockholder Equity	0.1	0.08	-0.15		-0.13	-0.45	0.78	-0.42	0.24	0.12	0.39	0.19	-0.28	-0.17	-0.13	-0.2	-0.13	-0.05	0.6	-0.4	-0.05	0.08	-0.38	-0.08	0.01	0.07
Property Plant And Equipment Net	0.79	0.8	0.75	-0.13		0.74	-0.2	0.9	-0.63	0.87	0.39	-0.6	0.69	-0.34	0.85	0.16	0.83	-0.16	0.15	0.51	-0.06	0.12	-0.13	0.66	0.8	0.67
Net Debt	0.57	0.46	0.55	-0.45	0.74		-0.28	0.69	-0.63	0.59	0.12	-0.58	0.57	-0.4	0.71	-0.08	0.67	0.02	0.0	0.84	-0.17	0.3	0.01	0.53	0.58	0.56
Retained Earnings	-0.03	-0.14	-0.29	0.78	-0.2	-0.28		-0.44	0.23	-0.01	0.22	0.21	-0.35	-0.6	-0.18	-0.75	-0.21	-0.07	0.29	-0.18	-0.38	0.25	-0.5	-0.19	-0.13	0.05
Accounts Payable	0.74	0.79	0.83	-0.42	0.9	0.69	-0.44		-0.46	0.78	0.28	-0.41	0.78	-0.27	0.84	0.2	0.85	-0.01	0.0	0.55	-0.04	0.14	0.02	0.7	0.78	0.65
Cash	-0.09	-0.22	-0.04	0.24	-0.63	-0.63	0.23	-0.46		-0.26	0.27	0.99	0.03	-0.03	-0.2	-0.19	-0.16	0.63	0.17	-0.12	-0.15	0.5	-0.14	-0.03	-0.09	0.07
Non Current Assets Total	0.97	0.91	0.9	0.12	0.87	0.59	-0.01	0.78	-0.26		0.72	-0.23	0.81	-0.45	0.94	0.04	0.94	0.07	0.5	0.57	-0.18	0.46	-0.3	0.83	0.96	0.88
Non Currrent Assets Other	0.74	0.55	0.63	0.39	0.39	0.12	0.22	0.28	0.27	0.72		0.28	0.63	-0.3	0.63	-0.04	0.64	0.22	0.53	0.34	-0.14	0.66	-0.27	0.62	0.73	0.75
Cash And Short Term Investments	-0.05	-0.21	0.0	0.19	-0.6	-0.58	0.21	-0.41	0.99	-0.23	0.28		0.08	-0.08	-0.15	-0.22	-0.11	0.68	0.13	-0.05	-0.2	0.54	-0.13	0.01	-0.05	0.12
Net Receivables	0.88	0.73	0.94	-0.28	0.69	0.57	-0.35	0.78	0.03	0.81	0.63	0.08		-0.34	0.93	0.16	0.94	0.46	0.21	0.75	-0.17	0.64	-0.12	0.84	0.93	0.89
Common Stock Shares Outstanding	-0.49	-0.29	-0.33	-0.17	-0.34	-0.4	-0.6	-0.27	-0.03	-0.45	-0.3	-0.08	-0.34		-0.48	0.8	-0.45	-0.24	-0.13	-0.55	0.65	-0.63	0.54	-0.36	-0.43	-0.62
Non Current Liabilities Total	0.97	0.85	0.95	-0.13	0.85	0.71	-0.18	0.84	-0.2	0.94	0.63	-0.15	0.93	-0.48		0.04	1.0	0.3	0.32	0.76	-0.22	0.58	-0.2	0.87	0.98	0.94
Other Stockholder Equity	0.02	0.22	0.18	-0.2	0.16	-0.08	-0.75	0.2	-0.19	0.04	-0.04	-0.22	0.16	0.8	0.04		0.08	-0.07	0.05	-0.25	0.61	-0.44	0.42	0.14	0.1	-0.16
Total Liab	0.97	0.87	0.97	-0.13	0.83	0.67	-0.21	0.85	-0.16	0.94	0.64	-0.11	0.94	-0.45	1.0	0.08		0.32	0.35	0.74	-0.19	0.57	-0.18	0.88	0.99	0.94
Total Current Assets	0.32	0.1	0.35	-0.05	-0.16	0.02	-0.07	-0.01	0.63	0.07	0.22	0.68	0.46	-0.24	0.3	-0.07	0.32		0.11	0.47	-0.16	0.68	0.04	0.35	0.32	0.49
Intangible Assets	0.5	0.56	0.41	0.6	0.15	0.0	0.29	0.0	0.17	0.5	0.53	0.13	0.21	-0.13	0.32	0.05	0.35	0.11		0.12	-0.03	0.35	-0.36	0.42	0.44	0.41
Short Long Term Debt Total	0.66	0.42	0.66	-0.4	0.51	0.84	-0.18	0.55	-0.12	0.57	0.34	-0.05	0.75	-0.55	0.76	-0.25	0.74	0.47	0.12		-0.33	0.73	-0.09	0.65	0.68	0.76
Other Current Assets	-0.21	0.03	-0.1	-0.05	-0.06	-0.17	-0.38	-0.04	-0.15	-0.18	-0.14	-0.2	-0.17	0.65	-0.22	0.61	-0.19	-0.16	-0.03	-0.33		-0.41	0.83	-0.19	-0.19	-0.33
Short Term Debt	0.61	0.3	0.55	0.08	0.12	0.3	0.25	0.14	0.5	0.46	0.66	0.54	0.64	-0.63	0.58	-0.44	0.57	0.68	0.35	0.73	-0.41		-0.3	0.57	0.6	0.78
Short Term Investments	-0.27	-0.15	-0.12	-0.38	-0.13	0.01	-0.5	0.02	-0.14	-0.3	-0.27	-0.13	-0.12	0.54	-0.2	0.42	-0.18	0.04	-0.36	-0.09	0.83	-0.3		-0.2	-0.23	-0.29
Common Stock	0.87	0.8	0.89	-0.08	0.66	0.53	-0.19	0.7	-0.03	0.83	0.62	0.01	0.84	-0.36	0.87	0.14	0.88	0.35	0.42	0.65	-0.19	0.57	-0.2		0.89	0.84
Other Liab	0.99	0.88	0.96	0.01	0.8	0.58	-0.13	0.78	-0.09	0.96	0.73	-0.05	0.93	-0.43	0.98	0.1	0.99	0.32	0.44	0.68	-0.19	0.6	-0.23	0.89		0.95
Other Assets	0.96	0.76	0.89	0.07	0.67	0.56	0.05	0.65	0.07	0.88	0.75	0.12	0.89	-0.62	0.94	-0.16	0.94	0.49	0.41	0.76	-0.33	0.78	-0.29	0.84	0.95

Click cells to compare fundamentals

CryoCell International Account Relationship Matchups

CryoCell International balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	46.2M	60.7M	64.9M	61.2M	70.4M	73.9M
Other Current Liab	2.9M	8.0M	5.6M	6.4M	7.3M	7.7M
Total Current Liabilities	16.4M	21.1M	19.5M	20.9M	24.0M	25.2M
Total Stockholder Equity	(2.7M)	4.2M	(1.5M)	(11.0M)	(9.9M)	(9.4M)
Property Plant And Equipment Net	1.9M	4.1M	14.2M	22.0M	25.3M	26.6M
Net Debt	(4.1M)	(5.4M)	9.9M	10.5M	9.4M	9.0M
Retained Earnings	(18.8M)	(16.7M)	(21.6M)	(31.2M)	(28.0M)	(29.4M)
Accounts Payable	957.4K	1.5M	1.6M	3.2M	3.7M	3.8M
Cash	10.4M	8.3M	1.7M	406.1K	467.0K	443.6K
Non Current Assets Total	27.6M	44.9M	55.3M	51.8M	59.5M	62.5M
Non Currrent Assets Other	11.6M	10.3M	9.9M	6.0M	6.9M	7.3M
Cash And Short Term Investments	10.4M	8.3M	1.7M	980.3K	1.1M	1.1M
Net Receivables	6.3M	5.3M	6.0M	6.6M	7.6M	7.9M
Common Stock Shares Outstanding	8.1M	8.4M	8.5M	8.3M	7.5M	7.8M
Liabilities And Stockholders Equity	46.2M	60.7M	64.9M	61.2M	70.4M	73.9M
Non Current Liabilities Total	32.5M	35.4M	46.9M	51.4M	59.1M	62.1M
Other Stockholder Equity	16.0M	20.8M	20.0M	20.0M	23.0M	21.5M
Total Liab	48.9M	56.5M	66.4M	72.3M	83.1M	87.2M
Total Current Assets	18.6M	15.8M	9.6M	9.5M	10.9M	10.5M
Intangible Assets	1.5M	16.2M	15.2M	989.1K	1.1M	2.0M
Short Long Term Debt Total	6.2M	2.8M	11.6M	10.9M	9.8M	9.3M
Other Current Assets	244.7K	711.2K	426.9K	390.0K	448.4K	770.9K
Short Term Debt	3.4M	2.2M	2.7M	1.6M	1.9M	1.6M
Short Term Investments	88.5K	75.4K	17.6K	574.2K	516.8K	641.7K
Common Stock	136.3K	146.7K	148.5K	148.5K	170.8K	134.7K
Other Liab	28.6M	29.6M	34.8M	38.0M	43.7M	45.9M
Other Assets	22.2M	21.9M	22.3M	23.7M	27.2M	28.6M
Long Term Debt	5.9M	2.8M	8.6M	8.4M	9.7M	5.2M
Property Plant Equipment	1.8M	1.6M	4.1M	14.2M	16.3M	17.2M
Current Deferred Revenue	9.2M	9.4M	9.6M	9.7M	11.2M	6.4M
Net Tangible Assets	(10.1M)	(2.7M)	(14.0M)	(18.6M)	(16.8M)	(17.6M)
Non Current Liabilities Other	32.5M	3.5M	2.0M	919.2K	827.3K	785.9K
Inventory	927.3K	921.2K	851.2K	768.9K	692.0K	657.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:

How To Invest In CryoCell

Details

Is CryoCell Stock a good investment?

Details

What is CryoCell International's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.625

Earnings Share

(1.07)

Revenue Per Share

3.89

Quarterly Revenue Growth

0.025

Return On Assets

(0)

The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CryoCell Historical Balance Sheet

CryoCell International Inventory

657,390

About CryoCell Balance Sheet Analysis

CryoCell International Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

CryoCell International balance sheet Correlations

CryoCell International Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CryoCell International balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Non Current Liabilities Total
Other Liab	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Other Liab	+ 0.99	Total Liab
Other Liab	+ 0.98	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Total Assets

Other Stockholder Equity	- 0.75	Retained Earnings
Short Term Debt	- 0.63	Common Stock Shares Outstanding
Cash	- 0.63	Net Debt
Cash	- 0.63	Property Plant And Equipment Net
Other Assets	- 0.62	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.6	Retained Earnings